The US Food and Drug Administration's expedited approval programs: Addressing premarket flexibility with enhanced postmarket evidence generation.

Overview
Research
Identity
Additional Document Info
View All

authors

Wallach, Joshua D
Joseph S. Ross, MD, MHS
Naci, Huseyin

publication date

January 2018

published in

Clinical trials (London, England) Journal

has subject area